Multiple signaling pathways and molecular targets

The term Multiple signaling pathways and molecular targets does not refer to a single, specific biological entity such as a protein, receptor, or enzyme. Instead, it is a descriptive phrase used in pharmacology and drug discovery to characterize drugs with polypharmacological profiles or to describe the complex network of interactions involved in disease progression (Hopkins, A. L., 2008, Nature Chemical Biology). This designation is often applied to multi-target ligands, such as certain kinase inhibitors or natural products, that exert their therapeutic effects by modulating several distinct cellular components simultaneously. Because it encompasses a broad range of unrelated molecular structures and biological processes, it cannot be defined by a single set of molecular classifications or functions. Consequently, this entry is considered an incorrect or overly broad target designation for structured drug-target databases and should be decomposed into specific molecular targets for accurate analysis.

Other names

PolypharmacologyMulti-target pharmacologyNetwork pharmacology

Not applicable as this is a collective term for various mechanisms rather than a single molecular interaction.